Chinese Pharmaceuticals & Biotech Undervalued Small Caps

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥11.7b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Beijing Strong BiotechnologiesInc

Market Cap: CN¥8.9b

Researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally.

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥11.9b

Engages in the blood product businesses in China.

Wuhan Hvsen BiotechnologyLtd

Market Cap: CN¥5.1b

Engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally.

Beijing Kawin Technology Share-Holding

Market Cap: CN¥4.5b

A biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥12.3b

A biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China.

Amoy Diagnostics

Market Cap: CN¥8.8b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥13.7b

Engages in research, development, production, and sales of blood products in China and internationally.